Chris H. Polman
Affiliations: | Neurology | VU University Medical Center, Amsterdam, Netherlands |
Area:
Multiple sclerosisWebsite:
http://www.msweb.nl/mszien-2014-1/513Google:
"Chris Hubert Polman"Bio:
http://www.neurosciencecampus-amsterdam.nl/en/people/program-leaders/interview-polman/index.asp
Mean distance: 20.17 (cluster 48)
Parents
Sign in to add mentor| Johan Carel Koetsier | grad student | 1988 | VU Amsterdam | |
| (Multiple Sclerosis and Experimental Allergic Encephalomyelitis: An Immunological Approach) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wiebenga OT, Schoonheim MM, Hulst HE, et al. (2016) White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology |
| Wattjes MP, Rovira À, Miller D, et al. (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nature Reviews. Neurology |
| Rovira À, Wattjes MP, Tintoré M, et al. (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nature Reviews. Neurology. 11: 471-82 |
| Kappos L, O'Connor P, Radue EW, et al. (2015) Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial. Neurology. 84: 1582-91 |
| Wiebenga OT, Klauser AM, Schoonheim MM, et al. (2015) Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. 36: 1116-23 |
| Vennegoor A, van Rossum JA, Polman CH, et al. (2015) Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England) |
| Tewarie P, Schoonheim MM, Schouten DI, et al. (2015) Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Human Brain Mapping. 36: 603-18 |
| Vennegoor A, Rispens T, Van Oosten BW, et al. (2015) Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 481-4 |
| Bosma LV, Sonder JM, Kragt JJ, et al. (2015) Detecting clinically-relevant changes in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 171-9 |
| Balk LJ, Steenwijk MD, Tewarie P, et al. (2015) Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 419-24 |